Provided by Tiger Trade Technology Pte. Ltd.

Agilent

125.97
+2.101.70%
Volume:367.20K
Turnover:46.11M
Market Cap:35.66B
PE:27.56
High:126.11
Open:123.64
Low:123.05
Close:123.87
52wk High:160.27
52wk Low:96.43
Shares:283.05M
Float Shares:283.00M
Volume Ratio:0.38
T/O Rate:0.13%
Dividend:0.99
Dividend Rate:0.79%
EPS(TTM):4.57
EPS(LYR):4.59
ROE:20.62%
ROA:8.48%
PB:5.29
PE(LYR):27.46

Loading ...

Earning Preview: Agilent Q1 revenue is expected to increase by 8.27%, and institutional views are Neutral

Earnings Agent
·
Yesterday

Agilent Technologies Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Yesterday

SovEcon Raises Russian Wheat Forecast -- Market Talk

Dow Jones
·
Feb 17

Champion Safe Wraps Successful Participation at Nation’s Best Sports Spring Annual Market in Oklahoma City

GlobeNewswire
·
Feb 17

TMD Energy Limited Announces Changes to Its Board of Directors

GlobeNewswire
·
Feb 17

Calendar of Canada Earnings Expected in the Week Ahead

Dow Jones
·
Feb 17

DBGI Announces Purchase of Existing Convertible Notes and Note Conversion Extension by Holders

GlobeNewswire
·
Feb 14

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement

GlobeNewswire
·
Feb 14

Press Release: Figure Technology Solutions Announces Preliminary Fourth Quarter & Full Year 2025 Financial Results

Dow Jones
·
Feb 13

Calendar of Canada Earnings Expected in the Week Ahead

Dow Jones
·
Feb 12

Quietly Powerful: Hoymiles HoyUltra 2 C&I ESS Achieves Breakthrough ≤60 dB(A) in Certified Noise Testing

prnewswire
·
Feb 12

Agilent gets FDA approval for PD-L1 IHC 22C3 pharmDx

TIPRANKS
·
Feb 12

Oak Woods Acquisition Corporation Announces Receipt of Nasdaq Staff Delisting Determination

GlobeNewswire
·
Feb 12

Revvity Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 12

Press Release: Agilent Announces Cash Dividend of 25.5 Cents per Share

Dow Jones
·
Feb 12

BRIEF-Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award

Reuters
·
Feb 11

Agilent's Ovarian Cancer Diagnostic Test Receives FDA Clearance

MT Newswires Live
·
Feb 11

Agilent Receives FDA Approval for Pd-L1 Ihc 22C3 Pharmdx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (Eoc)

THOMSON REUTERS
·
Feb 11

FDA Approves Agilent PD-L1 Test for First-Line Ovarian Cancer Therapy

Reuters
·
Feb 11

FDA Approves Pembrolizumab With Paclitaxel For Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Primary Peritoneal Carcinoma

Reuters
·
Feb 11